RegenExoBio
Book Consultation

Transforming
Regenerative Science
into Market-Ready
Innovation

Accelerating the lifecycle of advanced cellular therapies. From stem cell product development and strategic regulatory de-risking to global commercialization, we are your end-to-end growth partner.

Book Consultation Explore Services
🧬 Scientific Advisory
🔬 Biotech Consulting
✅ GMP & Regulatory
About Regenexo Advisory

About RegenExoBio

Advancing Regenerative Medicine Through Science,Innovation & Expertise

RegenExoBio is a specialized biotechnology and regenerative medicine consulting firm dedicated to driving innovation across the life sciences value chain. RegenExoBio was started by Dr. Lipi, a seasoned expert in the field of Regenerative Medicine and Biotechnology who was looking to close the scientific discovery to clinical translation, regulatory excellence and commercial success divide.

Dr. Lipi brings to RegenExoBio a deep expertise in stem cell therapy, exosome technology, cell and gene therapy, regenerative medicine, product development of biotechnology products and regulatory strategy, with a science-first approach. Her passion for innovation, excellence, and patient-centric care empowers organisations to bring pioneering ideas to life and turn them into safe, scalable, and commercially viable solutions.

Scientific
Excellence
Global
Compliance
Read Full Story

WHAT WE DO

End-to-end consulting solutions to accelerate innovation, ensure compliance, and drive successful market entry.

Regenerative
Product Development

From concept to formulation – exosome-based products, stem cell-derived innovations, and differentiated solutions.

Regulatory &
Compliance Consulting

Product classification, regulatory strategy (ICMR, DBT, CDSCO), global pathways, documentation, and SOP development.

Clinical Application
Strategy

Design of treatment protocols, procedure integration, and evidence-based approaches for safe clinical outcomes.

Market Entry &
Business Strategy

Go-to-market strategy, pricing, positioning, branding, and India & international expansion roadmaps.

Technology
Evaluation

Scientific due diligence, risk assessment, technology validation, and investment advisory.

WHY WORK WITH ME

A unique blend of scientific excellence, regulatory understanding, and industry experience.

  • 25+ years of experience in regenerative science
  • Stem cell & exosome research and product leadership
  • Deep understanding of DBT, ICMR, CDSCO & global regulations
  • Strong network in biotech, clinical & industry ecosystem
  • Bridging science, regulation, and commercialization

20+

Years of
Experience

100+

Projects
Consulted

50+

Clients
Worldwide

15+

Countries
Experience

100%

Commitment to
Compliance

WHO WE WORK WITH

Biotech Startups

From early-stage innovation to scalable, compliant biotech solutions.

Cosmeceutical
Companies

Science-backed product development and regulatory strategy for global markets.

Clinics &
Aesthetic Centers

Protocol design, treatment integration, and clinical excellence advisory.

Pharma /
Innovation Teams

R&D strategy, technology evaluation, and product commercialization support.

Investors &
Ventures

Scientific due diligence, risk assessment, and investment advisory.

INSIGHTS & RESOURCES

Knowledge, trends, and expert perspectives in regenerative science.

VIEW ALL INSIGHTS
Exosomes in Skincare

Exosomes in Skincare:
Regulatory Challenges

May 10, 2025 5 min read
Cosmetic vs Drug

Cosmetic vs Drug:
Key Decisions Explained

April 25, 2025 6 min read
Regenerative Aesthetics

Future of Regenerative
Aesthetics

April 12, 2025 4 min read
Cell & Gene Therapies

India's Regulatory Landscape
for Cell & Gene Therapies

March 28, 2025 6 min read

Ready to turn your science into
market-ready success?

Let's build the future of regenerative medicine together.

Book Consultation